Maven Biotechnologies LLC

Investment in women’s health has declined sharply since 2021, but venture companies expect start-ups with innovative solutions, especially in areas of high unmet need like menopause and endometriosis,

“Femtech” companies will branch in new directions in the coming years to address unmet needs and distance themselves from the competition in a women’s health market expected to reach a whopping $1.19t

“Femtech” companies will branch in new directions in the coming years to address unmet needs and distance themselves from the competition in a women’s health market expected to reach a whopping $1.19t